1. Lavoie MC, Koech E, Blanco N, Wangusi R, et al.
   Factors associated with enrollment into differentiated service delivery model among adults living with HIV in Kenya.
   AIDS 2023.
   


2. van Paassen PM, van Pul L, van der Straten K, Buchholtz NVJE, et al.
   Virological and immunological correlates of HIV post-treatment control after temporal antiretroviral therapy during acute HIV infection.
   AIDS 2023.
   


3. Burnett JC, Broz D, Berg J, Callens S, et al.
   Using serial cross-sectional surveys to create a retrospective nested cohort to determine HIV incidence from 20 U.S. Cities - 2008-2019.
   AIDS 2023.
   


4. Wan MM, Gill MJ, Fonseca K, Krentz H, et al.
   Neurologic infections in people with HIV: shifting epidemiological and clinical patterns.
   AIDS 2023.
   


5. Mustanski B, Ryan DT, Spinelli MA, Gandhi M, et al.
   Urine point-Of-care tenofovir test demonstrates strong predictive clinical and research utility.
   AIDS 2023.
   


6. Marcus ME, Mahlalela N, Drame ND, Rohr JK, et al.
   Home-based HIV testing strategies for middle-aged and older adults in rural South Africa: a randomized controlled trial.
   AIDS 2023.
   


7. Gatechompol S, Kerr SJ, Cardoso SW, Samaneka W, et al.
   Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.
   AIDS 2023.
   


8. Hong H, Dill-Mcfarland KA, Benson B, Simmons JD, et al.
   Mtb-induced Monocyte Transcriptional Responses Associate with Resistance to TST/IGRA Conversion in PLWH.
   AIDS 2023.
   


9. Bares SH, Wu X, Tassiopoulos K, Lake JE, et al.
   Weight gain after antiretroviral therapy initiation and subsequent risk of metabolic and cardiovascular disease.
   Clin Infect Dis 2023.
   


10. Costagliola D.
    Cardiovascular Diseases and Exposure to Integrase Inhibitors: Causal Interpretation of Treatment Effect in Observational Studies.
    Clin Infect Dis 2023;77:738-739.
    


11. Gleeson SE, Zapata H, Bathgate ME, Emu B, et al.
    Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.
    Clin Infect Dis 2023.
    


12. Freling S, Wald-Dickler N, Banerjee J, Canamar CP, et al.
    Real-world Application of Oral Therapy for Infective Endocarditis: A Multicenter Retrospective, Cohort Study.
    Clin Infect Dis 2023.
    


13. Gandhi M, Goosby E.
    PEPFAR Reauthorization by Congress Urgent for Global Health.
    JAMA 2023.
    


14. Harris E.
    Many Medicaid Enrollees Do Not Receive Needed HIV Care.
    JAMA 2023.
    


15. Sluis-Cremer N, Traverso Aviles EE, Gonzalez OQ, Rios-Velazquez C, et al.
    RING Program: The CFAR Diversity, Equity, and Inclusion Pathway Initiative.
    J Acquir Immune Defic Syndr 2023;94:S122-S126.
    


16. Irie WC, Chitneni P, Glynn TR, Allen W, et al.
    Pathways and Intersections: Multifaceted Approaches to Engage Individuals From Underrepresented and Marginalized Communities in HIV Research and Career Development.
    J Acquir Immune Defic Syndr 2023;94:S116-S121.
    


17. Delamerced J, Ramirez L, Kimberly JA, Vargas SI, et al.
    Going to the Source: Discussions With Early and Mid-Career Faculty From Groups Underrepresented in Biomedical Research to Develop and Enhance CFAR Services.
    J Acquir Immune Defic Syndr 2023;94:S108-S115.
    


18. Pallikkuth S, Andre M, Owens F, Davis S, et al.
    An Overview of Miami CDEIPI and a Showcase of Team Science and Cutting-Edge Research Driven by Students.
    J Acquir Immune Defic Syndr 2023;94:S93-S98.
    


19. Pereira FA, Newell AD, Rice AP.
    Texas Developmental Center for AIDS Research CFAR Diversity, Equity, and Inclusion Pathway Initiative Program.
    J Acquir Immune Defic Syndr 2023;94:S80-S85.
    


20. Dacus JD, Wood CV, Ward D.
    Partnering and Programming for a Black, Indigenous, and People of Color Sexual and Gender Minority Pathway to HIV Research.
    J Acquir Immune Defic Syndr 2023;94:S73-S79.
    


21. Okeke NL, Ware KB, Campbell R, Taylor J, et al.
    Evidence2Practice (E2P): Leveraging Implementation Science to Promote Careers in HIV Research Among Students From Historically Black Colleges and Universities.
    J Acquir Immune Defic Syndr 2023;94:S65-S72.
    


22. Balkus JE, Conde M, Lewin A, Walters KL, et al.
    Building Indigenuity, Generating HIV Science: An HIV/AIDS Research Training Program for Undergraduate and Graduate Indigenous Scholars (BIG HART).
    J Acquir Immune Defic Syndr 2023;94:S60-S64.
    


23. Flores JJ, Huang S, Sawyer S, Thomas M, et al.
    Developing an Inclusive Generation of HIV Researchers Through Diversity and Community.
    J Acquir Immune Defic Syndr 2023;94:S53-S59.
    


24. Koethe JR, Eeds A, Stewart LV, Haas DW, et al.
    The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes.
    J Acquir Immune Defic Syndr 2023;94:S42-S46.
    


25. Pitpitan EV, Campbell CK, Zuniga ML, Strathdee SA, et al.
    Supporting and Uplifting New and Diverse Scientists in HIV Research (San Diego SUN): A Research Education and Training Program to Promote the Success of Black, Indigenous, and People of Color Predoctoral and Postdoctoral Fellows.
    J Acquir Immune Defic Syndr 2023;94:S36-S41.
    


26. Kreider EF, Ortega-Burgos Y, Dumeng-Rodriguez J, Gesualdi J, et al.
    Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS Workforce.
    J Acquir Immune Defic Syndr 2023;94:S28-S35.
    


27. Sauceda JA, Watabe J, Sterling L, Fuchs J, et al.
    Accelerating Research Careers in Science Through Early Mentored Research Experiences for Undergraduates and Masters' Students at the University of California, San Francisco Center for AIDS Research.
    J Acquir Immune Defic Syndr 2023;94:S21-S27.
    


28. Magnus M, Segarra L, Robinson B, Blankenship K, et al.
    Impact of a Multi-Institutional Initiative to Engage Students and Early-Stage Scholars From Underrepresented Racial and Ethnic Minority Groups in HIV Research: The Centers for AIDS Research Diversity, Equity, and Inclusion Pathway Initiative.
    J Acquir Immune Defic Syndr 2023;94:S13-S20.
    


29. Greenberg AE, Wutoh A, Bowleg L, Robinson B, et al.
    Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI): Developing Career Pathways for Early-Stage Scholars From Racial and Ethnic Groups Underrepresented in HIV Science and Medicine.
    J Acquir Immune Defic Syndr 2023;94:S5-S12.
    


30. Hughes AJ, Nimbal V, Hsu L, Schwarcz S, et al.
    Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco.
    J Acquir Immune Defic Syndr 2023;94:107-115.
    


31. Dragoni F, Kwaa A, Traut CC, Veenhuis RT, et al.
    Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.
    J Clin Invest 2023.
    


32. Chien RN, Lu SN, Hui-Min Wu G, Yang WW, et al.
    Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan.
    J Infect Dis 2023;228:S180-S188.
    


33. Aaron A, Zhong H, Hiebert L, Zhuo Y, et al.
    Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study.
    J Infect Dis 2023;228:S189-S197.
    


34. Huang CF, Chen GJ, Hung CC, Yu ML, et al.
    HCV Microelimination for High-risk Special Populations.
    J Infect Dis 2023;228:S168-S179.
    


35. Umutesi J, Yu ML, Lesi O, Ward JW, et al.
    Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa.
    J Infect Dis 2023;228:S221-S225.
    


36. Davy-Mendez T, Napravnik S, Hogan BC, Eron JJ, et al.
    Hospital Readmissions among Persons with HIV in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies.
    J Infect Dis 2023.
    


37. Badillo-Paulina R, Juan Carlos RA, Lucia Del Carmen GF, Sergio SR, et al.
    Mpox-related ophthalmic disease: a retrospective observational study in a single center in Mexico.
    J Infect Dis 2023.
    


38. Yao X, Xu Z, Duan C, Zhang Y, et al.
    Role of human papillomavirus and associated viruses in bladder cancer: An updated review.
    J Med Virol 2023;95:e29088.
    


39. Dahal S, Clayton K, Cabral T, Cheng R, et al.
    On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
    J Virol 2023.
    


40. Zhang Z, Wang Q, Nguyen HT, Chen HC, et al.
    Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.
    J Virol 2023.
    


41. Zgheib S, Taha N, Zeiger M, Glushonkov O, et al.
    The human cellular protein NoL12 is a specific partner of the HIV-1 nucleocapsid protein NCp7.
    J Virol 2023.
    


42. Rao PG, Lambert GS, Upadhyay C.
    Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
    J Virol 2023.
    


43. Kharytonchyk S, Burnett C, Gc K, Telesnitsky A, et al.
    Transcription start site heterogeneity and its role in RNA fate determination distinguish HIV-1 from other retroviruses and are mediated by core promoter elements.
    J Virol 2023.
    


44. Gunst JD, Hojen JF, Pahus MH, Rosas-Umbert M, et al.
    Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.
    Nat Med 2023.
    

Display articles in

• Abstract format
• Medline format